After being fired, I became the light of medicine

Chapter 48 The Dean came to visit in person (Please read and vote for me!)

Zhang Yang did not continue the simulation as the long period of simulation was exhausting for him mentally.

but.

Before exiting the simulator, he extracted the crystal patent of "Acofenprofovir" that can cure hepatitis B as usual.

After finishing all this, he lay on the sofa and began to think about how to market this drug next.

Compared with "Qingshan Afa" or "ITG Human Myelopoietin", he is well aware that this drug that can cure hepatitis B is by no means comparable to the previous two drugs in terms of social influence and the number of target audiences.

Especially the social influence is not at the same level at all!
Just kidding, there are only about 150 million patients suffering from aplastic anemia in the country, and there are patients suffering from hepatitis B!

1.2 billion!
This means that one in ten Chinese people is infected!
Therefore, once this drug is launched on the market, it will inevitably cause a nationwide sensation. At that time, I and Qingshan Pharmaceutical will definitely be at the center of public attention.

How will we justify ourselves and explain the sources of drug research and development at that time?
Zhang Yang thought for a long time but couldn't come up with a good solution.

"Never mind... Let's just take it slow for now!"

"The most important issue now is to complete the Phase III clinical trial of 'ITG human myelopoietin' as soon as possible..."

"Besides this, I don't know how the Qingshan Avatrombopag is progressing in the hospital. The clinical trials of ITG epoxin and hepatitis B drugs will require a lot of funds, and they all depend on the sales profits of Qingshan Avatrombopag. I hope nothing unexpected will happen..."

"Oh, and the lab R&D team also needs to be expanded, which is also an expense..."

As he was thinking, Zhang Yang fell into a deep sleep.

……

The next morning, at 7:30, Zhang Yang woke up.

After a simple wash and breakfast, he came to the company and began to recall step by step his thoughts before going to bed last night.

That's right.

The first thing is to expand the laboratory research and development team.

At present, there are only four professional drug developers in Qingshan Pharmaceutical, including himself.
The previous "Qingshan Afa" and "ITG human ovulation hormone" can be explained by "Zhang Yang is extremely talented in the research and development of blood disease drugs". If a drug that can cure hepatitis B is developed next, how to explain it?

My boss Zhang Yang also has some talent for liver disease?

"Well, let's not ask for the quality of the personnel first, let's increase the quantity first!"

“It’s hard to find a real drug tycoon, but aren’t there a lot of three-legged pharmacy college students?”

"It's just that now the salary expenditure has suddenly increased several times..."

Zhang Yang did not expect the recruited drug developers to make any breakthroughs, so the recruitment information was sent out quickly. At the same time, he established a "Hepatitis B Drug Development Team" with himself as the team leader.

After dealing with the recruitment matters, Zhang Yang shifted his attention to the Phase III clinical trial of "ITG Human Myelopoietin".

The Phase III clinical trial of "ITG human ovarian hormone" requires a total of 550 trial subjects. Although there have been some minor incidents, more than 120 people have been successfully recruited.

It is expected that the remaining vacancies will be filled within a month.

Zhang Yang is not worried about "ITG Human Myelopoietin" passing the third phase. As for drugs like this that can achieve complete cure, as long as there are no major side effects, they will generally pass quickly!

Thinking of this, he set his sights on Qingshan Pharmaceutical's only product and the only source of profit - "Qingshan Avatrombopag".

Now "Qingshan Afa" has entered the sales cycle. I wonder how Ren Xiaomin's progress in promoting the admission of "Qingshan Afa" to hospitals has been after this week?

"It should be pretty good, right?"

"After all, Qingshan Afa not only has excellent efficacy, but is also included in the medical insurance catalogue. It should be easy for it to enter a tertiary hospital."

But at three o'clock in the afternoon, when Ren Xiaomin came to the office in a somewhat depressed mood, Zhang Yang's heart skipped a beat, realizing that this matter might not be as smooth as he had imagined.

"Brother Ren, what's wrong? Is the admission sales not going well?"

"Zhang Yang, I think we underestimated AkaRx. To be more precise, we underestimated the influence of their partner, Fuxing Pharmaceutical, in the hospital." "In the past week, we have made almost no progress in entering the hospital."

Zhang Yang was not in a hurry, but instead poured a glass of water for Ren Xiaomin.

"Brother Ren, take your time and tell me what's going on."

"Ah."

Ren Xiaomin picked up the cup and took a sip:
"After all, our Qingshan Pharmaceutical Sales Company is a new company and we don't have any hospital connections, so my idea is to start with our local tertiary hospitals in Chengdu and talk to them one by one."

"We have negotiated with two or three tertiary hospitals in the surrounding counties, and the drugs have been delivered to the hospitals. But as you know, tertiary hospitals are different from each other. There are not many patients in the hematology departments of the tertiary hospitals in these counties, so the purchase volume is very limited. A purchase of 200,000 or 300,000 is considered a lot."

"So, my focus is still on the truly large tertiary hospitals, such as Xihua Hospital."

"Xihua Hospital?"

Zhang Yang nodded slightly, agreeing with Ren Xiaomin's idea.

Xihua Hospital has a strong influence across the country. In the latest comprehensive ranking of Chinese hospitals, Xihua Hospital has ranked second for 15 consecutive years.

Although the Department of Hematology is not one of the top departments in Xihua University, this is Xihua University!
and so!
If I could sell it in the pharmacy of Xihua Hospital, the monthly sales amount would not be hundreds of thousands...

"What happened? Did the talks break down?" Zhang Yang asked.

"It would be fine if the talks broke down, but this week both the department director and the head of the pharmacy department avoided me. I haven't even seen them in a week!"

"After thinking about it carefully, I guess it must be Fuxing Pharmaceutical that is behind this. After all, Xihua Hospital is now purchasing their 'Avatrombopag'."

As he spoke, Ren Xiaomin sighed:
"I now truly understand the saying that pharmaceutical sales is not about fighting and killing, but about human relationships and worldly wisdom..."

Zhang Yang didn't find it strange. After all, in a channel that requires connections, there's really nothing you can do if you don't have any connections.

But after a moment, he suddenly asked:
"Then can the current profits of Qingshan Afa support the Phase III clinical trial of ITG human genotype?"

"That's enough! There's no problem supporting the completion of Phase III clinical trials!"

Zhang Yang felt relieved, his thoughts gradually became clearer. He patted Ren Xiaomin on the shoulder and comforted him:

"In that case, Brother Ren, don't be too stressed and take it slow."

"They have reason to reject Qingshan Avatrombopag now. I want to see how many hospitals will reject ITG human myelopoietin after it is launched on the market..."

Ren Xiaomin was stunned, then he understood what Zhang Yang meant.

After Qingshan Afa’s admission to the hospital failed, Zhang Yang did not think of continuing to force Qingshan Afa to be admitted to the hospital.

After comforting Ren Xiaomin, he then focused all his energy on the Phase III clinical trial of "ITG Human Myelopoietin" as well as the subsequent production links and production approval!

This is the medicine that can cure aplastic anemia!
Which hospital with a hematology department would not purchase it by then? !

Soon, a month later.

The first month's clinical data of the Phase III clinical trial of "ITG Human Myelogenin" was released on the official website of the State Food and Drug Administration!
After just one month of treatment, the bone marrow hematopoietic stem cells of some subjects actually showed functional improvement!
As soon as the news came out, domestic pharmaceutical companies were shocked and it instantly caused a sensation within the industry!
When the clinical data came out the second month, major pharmaceutical companies were even more shocked.

After two months of drug treatment, the effective responses of the participating clinical subjects increased significantly, and the degree of bone marrow cell proliferation in some patients began to return to normal!
In other words, it can almost be concluded that "ITG human myelopoietin" is really effective in treating aplastic anemia!

The news quickly spread throughout the industry, but what Zhang Yang didn't expect was that
Domestic pharmaceutical companies were not in a hurry. Instead, Director Zhou of Chengdu Third People's Hospital came to us first!
"Hello, Mr. Zhang. I really wanted to talk to you before, but I never saw you."

"This time, I'm going to discuss a cooperation with you."

Looking at Director Zhou of the Third People's Hospital of Chengdu, Zhang Yang was a little confused.

Hospital?

cooperate? !
(End of this chapter)